The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats

Exp Neurol. 2016 Aug:282:27-36. doi: 10.1016/j.expneurol.2016.05.007. Epub 2016 May 6.

Abstract

Oscillatory activity has been well-studied in many structures within cortico-basal ganglia circuits, but it is not well understood within the pedunculopontine nucleus (PPN), which was recently introduced as a potential target for the treatment of gait and postural impairments in advanced stages of Parkinson's disease (PD). To investigate oscillatory activity in the PPN and its relationship with oscillatory activity in cortico-basal ganglia circuits, we simultaneously recorded local field potentials in the PPN, primary motor cortex (M1), and subthalamic nucleus (STN) of 6-hydroxydopamine (6-OHDA)-induced hemiparkinsonian rats during resting and walking. After analysis of power spectral density, coherence, and partial Granger causality, three major findings emerged: 1) after 6-OHDA lesions, beta band oscillations were enhanced in all three regions during walking; 2) the direction of information flow for beta oscillations among the three structures was STN→M1, STN→PPN, and PPN→M1; 3) after the treatment of levodopa, beta activity in the three regions was reduced significantly and the flow of beta band was also abrogated. Our results suggest that beta activity in the PPN is transmitted from the basal ganglia and probably comes from the STN, and the STN plays a dominant role in the network of causal interactions for beta activity. Thus, the STN may be a potential source of aberrant beta band oscillations in PD. Levodopa can inhibit beta activity in the PPN of parkinsonian rats but cannot relieve parkinsonian patients' axial symptoms clinically. Therefore, beta oscillations may not be the major cause of axial symptoms.

Keywords: Beta band oscillations; Local field potentials; Parkinson's disease; Parkinsonian rats; Pedunculopontine nucleus; Primary motor cortex; Subthalamic nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use
  • Beta Rhythm / physiology*
  • Disease Models, Animal
  • Levodopa / pharmacology
  • Levodopa / therapeutic use
  • Male
  • Motor Cortex / physiopathology*
  • Oxidopamine / toxicity
  • Parkinson Disease / drug therapy
  • Parkinson Disease / etiology
  • Parkinson Disease / pathology*
  • Parkinson Disease / physiopathology
  • Pedunculopontine Tegmental Nucleus / physiopathology*
  • Rats
  • Rats, Sprague-Dawley
  • Spectrum Analysis
  • Subthalamic Nucleus / physiopathology*
  • Tyrosine 3-Monooxygenase / metabolism
  • Walking / physiology*

Substances

  • Antiparkinson Agents
  • Levodopa
  • Oxidopamine
  • Tyrosine 3-Monooxygenase